Luca Gianni
Division of Medical Oncology
Istituto Nazionale Tumori
Milan
Italy
Name/email consistency: high
- Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer. Gianni, L., Zambetti, M., Clark, K., Baker, J., Cronin, M., Wu, J., Mariani, G., Rodriguez, J., Carcangiu, M., Watson, D., Valagussa, P., Rouzier, R., Symmans, W.F., Ross, J.S., Hortobagyi, G.N., Pusztai, L., Shak, S. J. Clin. Oncol. (2005)
- Feasibility and tolerability of sequential doxorubicin/paclitaxel followed by cyclophosphamide, methotrexate, and fluorouracil and its effects on tumor response as preoperative therapy. Gianni, L., Baselga, J., Eiermann, W., Guillem Porta, V., Semiglazov, V., Lluch, A., Zambetti, M., Sabadell, D., Raab, G., Llombart Cussac, A., Bozhok, A., Martinez-Agulló, A., Greco, M., Byakhov, M., Lopez Lopez, J.J., Mansutti, M., Valagussa, P., Bonadonna, G. Clin. Cancer Res. (2005)
- Anthracyclines. Gianni, L., Grasselli, G., Cresta, S., Locatelli, A., Viganò, L., Minotti, G. Cancer. Chemother. Biol. Response. Modif (2003)
- Anthracyclines. Gianni, L., Grasselli, G., Cresta, S., Locatelli, A., Viganò, L., Minotti, G. Cancer. Chemother. Biol. Response. Modif (2002)
- Tolerability in patients receiving trastuzumab with or without chemotherapy. Gianni, L. Ann. Oncol. (2001)
- Cardiac function following combination therapy with paclitaxel and doxorubicin: an analysis of 657 women with advanced breast cancer. Gianni, L., Dombernowsky, P., Sledge, G., Martin, M., Amadori, D., Arbuck, S.G., Ravdin, P., Brown, M., Messina, M., Tuck, D., Weil, C., Winograd, B. Ann. Oncol. (2001)
- Human pharmacokinetic characterization and in vitro study of the interaction between doxorubicin and paclitaxel in patients with breast cancer. Gianni, L., Viganò, L., Locatelli, A., Capri, G., Giani, A., Tarenzi, E., Bonadonna, G. J. Clin. Oncol. (1997)
